Halozyme Therapeutics
HALO
#1943
Rank
$6.99 B
Marketcap
$51.77
Share price
1.27%
Change (1 day)
49.58%
Change (1 year)

P/S ratio for Halozyme Therapeutics (HALO)

P/S ratio as of January 2023 (TTM): 12.0

According to Halozyme Therapeutics's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 12.0176. At the end of 2022 the company had a P/S ratio of 9.49.

P/S ratio history for Halozyme Therapeutics from 2005 to 2022

PS ratio at the end of each year

Year P/S ratio Change
20229.49-25.72%
202112.8-40.81%
202021.674.46%
201912.4-11.3%
201813.953.06%
20179.114.45%
20168.72-46.96%
201516.42.11%
201416.1-48.6%
201331.375.34%
201217.91.63%
201117.6-69.93%
201058.548.53%
200939.4-24.36%
200852.0-64.3%
2007146-74.13%
2006564-33.42%
2005847

P/S ratio for similar companies or competitors

Company P/S ratio P/S ratio differencediff. Country
4.40-63.38%๐Ÿ‡บ๐Ÿ‡ธ USA
2.44-79.66%๐Ÿ‡บ๐Ÿ‡ธ USA
11.1-7.97%๐Ÿ‡บ๐Ÿ‡ธ USA
2.60-78.38%๐Ÿ‡ซ๐Ÿ‡ท France
1.56-87.02%๐Ÿ‡บ๐Ÿ‡ธ USA
18.6 55.15%๐Ÿ‡บ๐Ÿ‡ธ USA